HAPILA reaching completion of design for new GMP production plant for APIs

Gera, Germany: – High-potency active ingredient specialist CDMO HAPILA GmbH (HAPILA) is ramping up its production capacity with two new GMP plants now in its manufacturing pipeline.

HAPILA has almost completed concept design and identified a 240m2 site for one new GMP production plant with capacities up to 600 liters and necessary filtration and drying capacities. It is also preparing technical specifications for another facility. Both plants are being designed to handle custom synthesis under GMP compliance to meet growing pharma industry demand for high quality APIs manufactured in the European Union.

Source: HAPILA GmbH